A Message from Dr. Love
The outpouring of support my family and I have received since letting people know about my leukemia diagnosis has left me speechless.
It is one thing to be diagnosed with cancer. It is quite another to know that thousands of women and men have me in their thoughts as I embark on my personal journey to cancer survivorship.
Having completed a few marathons, I can say I know a bit about endurance, and fighting through pain. I expected to draw open that experience during my treatment. Now, I will also draw upon the words so many of you shared: words of hope, words of inspiration, and words of encouragement.
I love Joan’s image of my cancer cells being smothered by my good karma. And as Liz, Carol, and Kathy each reminded me: I have the love and support of an entire Army of Women behind me—and leukemia doesn’t stand a chance against this Army!
I’m off to do what Casey said “kick its a** and teach us more than you already have by doing so.”
I will update you soon.
Dr. Susan Love
LEAVE A MESSAGE FOR DR. LOVE >
The 2012 American Society of Clinical Oncology meeting took place in Chicago June 1 to June 5. There were lots of headlines generated but, as we all know all too well, that doesn’t mean there was necessarily a lot of studies presented that are going to start changing clinical practice. Also, it’s important to keep in mind that just because a study is presented at a conference doesn’t mean it’s going to get peer-reviewed and published. It’s estimated that less than half of all the abstracts presented at biomedical meetings go on to be published. Be a critical consumer of medical news, and remember that the headlines you see generated from abstracts should be considered preliminary, and not the final word.
Read our round up of stories on breast cancer risk and childhood chest radiation for Hodgkin’s lymphoma; the new drug T-DM1 that delivers trastuzumab (Herceptin) and chemo; treating HER2-positive metastatic breast cancer with Herceptin and a taxane; the taxol study that showed new, expensive drugs aren’t always better; ginseng for cancer-related fatigue; and cymbalta for chemo-related neuropathy. MORE >
Do you have a topic you think we should address? Send us an email and tell us what's on your mind.